LEADER 01143nam0-2200421-i-450- 001 990009200530403321 005 20151016082632.0 010 $a978-0-470-08585-1 035 $a000920053 035 $aFED01000920053 035 $a(Aleph)000920053FED01 035 $a000920053 100 $a20100618d2009----km-y0itay50------ba 101 0 $aeng 102 $aUS 105 $aa---a---001yy 200 1 $aBioinformatics and functional genomics$fJonathan Pevsner 205 $a2. ed. 210 $aHoboken, N.J.$cWiley-Blackwell$d2009 215 $aXXVIII, 951 p.$d28 cm 452 0$1001000979552 610 0 $aGenomica 610 0 $aBioinformatica 610 0 $aProteomica 610 0 $aBiologia computazionale$aMetodi 610 0 $aTecniche genetiche 676 $a572.8$v22 700 1$aPevsner,$bJonathan$0508242 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a990009200530403321 952 $aMAI-92-029$b24341$fMA1 952 $a60 572.8 B 12$b12981$fFAGBC 959 $aMA1 959 $aFAGBC 962 $a92-XX 996 $aBioinformatics and functional genomics$9774959 997 $aUNINA LEADER 03401nam 2200901z- 450 001 9910557205303321 005 20220111 035 $a(CKB)5400000000041887 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76280 035 $a(oapen)doab76280 035 $a(EXLCZ)995400000000041887 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aFungal Infections Complicating COVID-19 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (98 p.) 311 08$a3-0365-0554-7 311 08$a3-0365-0555-5 330 $aCoronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections, a significant proportion of cases progress to severe pneumonia and acute respiratory distress syndrome requiring critical care. Opportunistic infections following severe respiratory viral infections have been recognized since the 1918 influenza pandemic. Among critically ill patients with COVID-19, secondary fungal infections caused by Aspergillus and Candida spp. are increasingly described, affecting up to 30% of COVID-19 patients requiring intensive care treatment. This collection of manuscripts focuses on fungal infections complicating COVID-19, including immunological mechanisms and pathogenesis, diagnosis, and treatment. 606 $aMedicine and Nursing$2bicssc 610 $aAspergillus 610 $aAspergillus fumigatus 610 $aazole-resistant Aspergillus 610 $abloodstream infection 610 $aCandida glabrata 610 $acandidemia 610 $acandiduria 610 $aCAPA 610 $achallenges 610 $aclassification 610 $aco-infection 610 $aco-infections 610 $acoinfection 610 $aCOVID-19 610 $aCOVID-19 associated invasive pulmonary aspergillosis 610 $aCOVID-19 pneumonia 610 $adiabetes 610 $adiagnosis 610 $aechinocandin resistance 610 $aEuropean Confederation of Medical Mycology 610 $aexpert statement 610 $aFKS mutation 610 $afungaemia 610 $agalactomannan 610 $aICU 610 $aimmune response 610 $ainvasive aspergillosis 610 $ainvasive pulmonary aspergillosis 610 $amulti-triazole resistance 610 $amycobiome 610 $an/a 610 $anovel coronavirus 610 $aoral candidiasis 610 $aPCR 610 $aprevalence 610 $aprobable 610 $apulmonary aspergillosis 610 $aputative 610 $arisk factors 610 $aSaccharomyces 610 $aSARS COV-2 610 $aSars-CoV-2 610 $aSARS-CoV-2 610 $asuperinfection 610 $aTR34L98H 615 7$aMedicine and Nursing 700 $aHoenigl$b Martin$4edt$01287896 702 $aTalento$b Alida Fe$4edt 702 $aHoenigl$b Martin$4oth 702 $aTalento$b Alida Fe$4oth 906 $aBOOK 912 $a9910557205303321 996 $aFungal Infections Complicating COVID-19$93036854 997 $aUNINA